May require fee or membership

The slides from this informative webinar will aid drug court team members in tracking treatment progress and ensuring that participants adhere to medication in addiction treatment. jointly sponsored by the National Association of Drug Court Professionals and the American Society of Addiction Medicine, this webinar was designed especially for judges, coordinators, prosecutors, defense attorneys, supervision officers, case managers, and other team members who refer, monitor, or otherwise support behavioral health treatment in drug courts.

Webinar that provides information about how pharmacotherapy can help support evidence-based treatment practices for alcohol dependence; reviews myths, opinions, and biases and the environment of addiction treatment; compares the 4 FDA-approved pharmacotherapies for alcohol dependence; enables participants to receive1.5 continuing education credits

Available to existing Epic outpatient software users; uses the AUDIT-C and assesses other risk factors (e.g., social determinants of health), allowing users to customize if needed

Describes 12-step programs and how providers can help their patients get to and best use these programs, including patients taking medications for substance use disorder; up to 1 AMA PRA Category 1 Credit (TM) for continuing education

Describes and compares pharmacological treatment options for individuals with AUD, including FDA- approved medications acamprosate, disufiram, and naltrexone, as well as two other evidence-based treatments that are not yet FDA approved, topiramate and gabapentin; includes diagnosis of AUD, definitions of binge drinking and “at risk” drinking, and a case vignette; up to 1 AMA PRA Category 1 Credit™ for continuing education